{"entity":{"type":"insider","cik":"0001553354","url":"/insider/0001553354","json_url":"/insider/0001553354.json","name":"Hager Alicia J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":19,"first":"2015-04-29","last":"2025-01-17","span_basis":"filed_date"},"name_variants":[{"name":"Hager Alicia J.","source":"filing","n_filings":19,"first_seen":"2015-04-29","last_seen":"2025-01-17"}],"transactions":[{"id":4193590,"accession":"0000950170-25-006823","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-006823","line_url":"/filing/0000950170-25-006823#line-1","is_derivative":false,"issuer_cik":"0001553354","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001553354","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9584.0,"shares_display":"9,584","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":21084.8,"total_display":"21,084.80","total_whole":"21,085","shares_owned_after":146735.0,"shares_owned_after_display":"146,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-15","filed_date":"2025-01-17","scope":"insider"},{"id":2305296,"accession":"0000950170-24-084588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-084588","line_url":"/filing/0000950170-24-084588#line-1","is_derivative":false,"issuer_cik":"0001553354","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001553354","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3396.0,"shares_display":"3,396","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":27168.0,"total_display":"27,168.00","total_whole":"27,168","shares_owned_after":103819.0,"shares_owned_after_display":"103,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-18","scope":"insider"},{"id":2736768,"accession":"0000950170-24-075728","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-075728","line_url":"/filing/0000950170-24-075728#line-1","is_derivative":false,"issuer_cik":"0001553354","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001553354","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":727.0,"shares_display":"727","price_per_share":5.6,"price_display":"5.60","price_state":"stated","total_value":4071.2,"total_display":"4,071.20","total_whole":"4,071","shares_owned_after":107215.0,"shares_owned_after_display":"107,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-20","scope":"insider"},{"id":2414638,"accession":"0000950170-24-005425","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-005425","line_url":"/filing/0000950170-24-005425#line-1","is_derivative":false,"issuer_cik":"0001553354","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001553354","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4554.0,"shares_display":"4,554","price_per_share":8.74,"price_display":"8.74","price_state":"stated","total_value":39801.96,"total_display":"39,801.96","total_whole":"39,802","shares_owned_after":107942.0,"shares_owned_after_display":"107,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-18","scope":"insider"},{"id":8724016,"accession":"0001209191-23-039057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-039057","line_url":"/filing/0001209191-23-039057#line-1","is_derivative":false,"issuer_cik":"0001553354","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001553354","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":701.0,"shares_display":"701","price_per_share":4.85,"price_display":"4.85","price_state":"stated","total_value":3399.85,"total_display":"3,399.85","total_whole":"3,400","shares_owned_after":56496.0,"shares_owned_after_display":"56,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-22","scope":"insider"},{"id":8677304,"accession":"0001209191-23-003852","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-003852","line_url":"/filing/0001209191-23-003852#line-2","is_derivative":false,"issuer_cik":"0001553354","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTX","issuer_name_source":null,"issuer_url":"/issuer/0001553354","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1103.0,"shares_display":"1,103","price_per_share":5.49,"price_display":"5.49","price_state":"stated","total_value":6055.47,"total_display":"6,055.47","total_whole":"6,055","shares_owned_after":57197.0,"shares_owned_after_display":"57,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-18","scope":"insider"},{"id":6672472,"accession":"0001567619-18-004055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-004055","line_url":"/filing/0001567619-18-004055#line-1","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1156.0,"shares_display":"1,156","price_per_share":2.02,"price_display":"2.02","price_state":"stated","total_value":2335.12,"total_display":"2,335.12","total_whole":"2,335","shares_owned_after":51754.0,"shares_owned_after_display":"51,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-10","filed_date":"2018-10-11","scope":"insider"},{"id":6427982,"accession":"0001567619-18-003955","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-003955","line_url":"/filing/0001567619-18-003955#line-1","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1686.0,"shares_display":"1,686","price_per_share":2.1288,"price_display":"2.13","price_state":"stated","total_value":3589.1568,"total_display":"3,589.16","total_whole":"3,589","shares_owned_after":52910.0,"shares_owned_after_display":"52,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-09","filed_date":"2018-10-10","scope":"insider"},{"id":6627977,"accession":"0001140361-18-019831","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-019831","line_url":"/filing/0001140361-18-019831#line-1","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4051.0,"shares_display":"4,051","price_per_share":2.6778,"price_display":"2.68","price_state":"stated","total_value":10847.7678,"total_display":"10,847.77","total_whole":"10,848","shares_owned_after":54596.0,"shares_owned_after_display":"54,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-24","filed_date":"2018-04-26","scope":"insider"},{"id":4126561,"accession":"0001140361-17-038564","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-038564","line_url":"/filing/0001140361-17-038564","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1248.0,"shares_display":"1,248","price_per_share":4.242485576923077,"price_display":"4.24","price_state":"stated","total_value":5294.622,"total_display":"5,294.62","total_whole":"5,295","shares_owned_after":58647.0,"shares_owned_after_display":"58,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-10","filed_date":"2017-10-12","scope":"insider","n_lines":2},{"id":4285984,"accession":"0001140361-17-015046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-015046","line_url":"/filing/0001140361-17-015046","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4316.0,"shares_display":"4,316","price_per_share":9.056836515291938,"price_display":"9.06","price_state":"stated","total_value":39089.3064,"total_display":"39,089.31","total_whole":"39,089","shares_owned_after":21561.0,"shares_owned_after_display":"21,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-04","filed_date":"2017-04-05","scope":"insider","n_lines":2},{"id":4588429,"accession":"0001140361-17-012630","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-012630","line_url":"/filing/0001140361-17-012630#line-2","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6652.0,"shares_display":"6,652","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":66520.0,"total_display":"66,520.00","total_whole":"66,520","shares_owned_after":25877.0,"shares_owned_after_display":"25,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2017-03-17","scope":"insider"},{"id":2963269,"accession":"0001140361-16-047335","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-16-047335","line_url":"/filing/0001140361-16-047335#line-3","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1.0,"shares_display":"1","price_per_share":21.33,"price_display":"21.33","price_state":"stated","total_value":21.33,"total_display":"21.33","total_whole":"21","shares_owned_after":13377.0,"shares_owned_after_display":"13,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-07","filed_date":"2016-01-08","scope":"insider"},{"id":2963264,"accession":"0001140361-16-047335","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-047335","line_url":"/filing/0001140361-16-047335","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1622.0,"shares_display":"1,622","price_per_share":22.276295930949445,"price_display":"22.28","price_state":"stated","total_value":36132.152,"total_display":"36,132.15","total_whole":"36,132","shares_owned_after":13430.0,"shares_owned_after_display":"13,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-06","filed_date":"2016-01-08","scope":"insider","n_lines":2},{"id":8800500,"accession":"0001140361-15-043281","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-043281","line_url":"/filing/0001140361-15-043281#line-2","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":23.1412,"price_display":"23.14","price_state":"stated","total_value":41654.16,"total_display":"41,654.16","total_whole":"41,654","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-27","filed_date":"2015-12-01","scope":"insider"},{"id":8448702,"accession":"0001140361-15-038993","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-038993","line_url":"/filing/0001140361-15-038993#line-2","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5400.0,"shares_display":"5,400","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":113400.0,"total_display":"113,400.00","total_whole":"113,400","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-27","filed_date":"2015-10-29","scope":"insider"},{"id":8607880,"accession":"0001140361-15-028996","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-028996","line_url":"/filing/0001140361-15-028996#line-2","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":37800.0,"total_display":"37,800.00","total_whole":"37,800","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-28","filed_date":"2015-07-29","scope":"insider"},{"id":8672291,"accession":"0001140361-15-026072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-026072","line_url":"/filing/0001140361-15-026072#line-2","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":22.6654,"price_display":"22.67","price_state":"stated","total_value":40797.72,"total_display":"40,797.72","total_whole":"40,798","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-29","filed_date":"2015-06-30","scope":"insider"},{"id":8607473,"accession":"0001140361-15-022160","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-022160","line_url":"/filing/0001140361-15-022160#line-2","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":23.0706,"price_display":"23.07","price_state":"stated","total_value":41527.08,"total_display":"41,527.08","total_whole":"41,527","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-27","filed_date":"2015-05-28","scope":"insider"},{"id":8924299,"accession":"0001140361-15-016864","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-15-016864","line_url":"/filing/0001140361-15-016864","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001553354","owner_name":"Hager Alicia J.","owner_display_name":"Hager Alicia J.","owner_url":"/insider/0001553354","role":"Officer (VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":25.651255,"price_display":"25.65","price_state":"stated","total_value":46172.259,"total_display":"46,172.26","total_whole":"46,172","shares_owned_after":15855.0,"shares_owned_after_display":"15,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-27","filed_date":"2015-04-29","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001787400","name":"Nkarta, Inc.","url":"/issuer/0001787400","role":"Officer (Chief Legal Officer)","n_filings":6,"first_seen":"2023-01-18","last_seen":"2025-01-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001302573","name":"OncoMed Pharmaceuticals Inc","url":"/issuer/0001302573","role":"Officer (SVP & General Counsel)","n_filings":13,"first_seen":"2015-04-29","last_seen":"2018-10-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001553354","retrieved_at":"2026-08-25T06:04:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}